Alvotech plant issues foil another FDA review, this time for Teva-partnered Simponi biosimilar
Alvotech Plant Faces FDA Setback on Simponi Biosimilar Patients seeking a more affordable alternative to Johnson & Johnson’s anti-inflammatory drug Simponi may face delays. An FDA inspect…